Fat oxidation, appetite and weight control

Food, Diet and Obesity

Volumn , Issue , 2005, Pages 356-378

  Leonhardt, M ^a   Langhans, W ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902558134     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845690540.3.356     Document Type: Chapter

References (151)

1. Abu-Elheiga L., Matzuk M.M., Abo-Hashema K.A., Wakil S.J. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 2001, 291:2613-2616.
2. Aguilera A.A., Diaz G.H., Barcelata M.L., Guerrero O.A., Ros R.M.O. Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor-alpha in rats with sucrose-induced metabolic syndrome. Journal of Nutritional Biochemistry 2004, 15:350-357.
3. Alsaif M.A., Duwaihy M.M.S. Influence of dietary fat quantity and composition on glucose tolerance and insulin sensitivity in rats. Nutrition Research 2004, 24:417-425.
4. Aminot-Gilchrist D.V., Anderson H.D.I. Insulin resistance-associated cardiovascular disease: potential benefits of conjugated linoleic acid. American Journal of Clinical Nutrition 2004, 79:1159S-S1163S.
5. Astrup A., Grunwald G.K., Melanson E.L., Saris W.H.M., Hill J.O. The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies. International Journal of Obesity 2000, 24:1545-1552.
6. Azain M.J., Hausman D.B., Sisk M.B., Flatt W.P., Jewell D.E. Dietary conjugated linoleic acid reduces rat adipose tissue cell size rather than cell number. Journal of Nutrition 2000, 130:1548-1554.
7. Bach A.C., Ingenbleek Y., Frey A. Usefulness of dietary medium-chain triglycerides in body weight control: Fact or fancy?. Journal of Lipid Research 1996, 37:708-726.
8. Bergman R.N. Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein?. Diabetologia 2000, 43:946-952.
9. Beverly J.L., Yang Z.J., Meguid M.M. Hepatic vagotomy effects on metabolic challenges during parenteral-nutrition in rats. American Journal of Physiology - Regulatory Integrative and Comparative Physiology 1994, 266:R646-R649.
10. Binnert C., Pachiaudi C., Beylot M., et al. Influence of human obesity on the metabolic fate of dietary long- and medium-chain triacylglycerols. American Journal of Clinical Nutrition 1998, 67:595-601.
11. Blaak E. Gender differences in fat metabolism. Current Opinion in Clinical Nutrition and Metabolic Care 2001, 4:499-502.
12. Blundell J.E., Stubbs R.J. High and low carbohydrate and fat intakes: limits imposed by appetite and palatability and their implications for energy balance. European Journal of Clinical Nutrition 1999, 53:S148-S165.
13. Bravata D.M., Sanders L., Huang J., et al. Efficacy and safety of low-carbohydrate diets - a systematic review. Journal of the American Medical Association 2003, 289:1837-1850.
14. Bray G.A., Lee M., Bray T.L. Weight-gain of rats fed medium-chain triglycerides is less than rats fed long-chain triglycerides. International Journal of Obesity 1980, 4:27-32.
15. Bray G.A., Popkin B.M. Dietary fat intake does affect obesity!. American Journal of Clinical Nutrition 1998, 68:1157-1173.
16. Brehm B.J., Seeley R.J., Daniels S.R., D'alessio D.A. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. Journal of Clinical Endocrinology and Metabolism 2003, 88:1617-1623.
17. Clarke S.D. Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance. British Journal of Nutrition 2000, 83:S59-66.
18. Clegg D.J., Wortman M.D., Benoit S.C., Mcosker C.C., Seeley R.J. Comparison of central and peripheral administration of C75 on food intake, body weight, and conditioned taste aversion. Diabetes 2002, 51:3196-3201.
19. Corbel S.Y., Rossi F.M. Latest developments and in vivo use of the Tet system: ex vivo and in vivo delivery of tetracycline-regulated genes. Current Opinion in Biotechnology 2002, 13:448-452.
20. Dashti H.M., Bo-Abbas Y.Y., Asfar S.K., et al. Ketogenic diet modifies the risk factors of heart disease in obese patients. Nutrition 2003, 19:901-902.
21. Deems R.O., Anderson R.C., Foley J.E. Hypoglycemic effects of a novel fatty acid oxidation inhibitor in rats and monkeys. American Journal of Physiology - Regulatory Integrative and Comparative Physiology 1998, 274:R524-R528.
22. Degen L., Matzinger D., Drewe J., Beglinger C. The effect of cholecystokinin in controlling appetite and food intake in humans. Peptides 2001, 22:1265-1269.
23. Del Prete E., Lutz T.A., Scharrer E. Transient hypophagia in rats switched from high-fat diets with different fatty-acid pattern to a high-carbohydrate diet. Appetite 2000, 34:137-145.
24. Delany J.P., Blohm F., Truett A.A., Scimeca J.A., West D.B. Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. American Journal of Physiology - Regulatory Integrative and Comparative Physiology 1999, 276:R1172-R1179.
25. Delany J.P., Windhauser M.M., Champagne C.M., Bray G.A. Differential oxidation of individual dietary fatty acids in humans. American Journal of Clinical Nutrition 2000, 72:905-911.
26. Denbow D.M., Vankrey H.P., Lacy M.P., Watkins B.A. The effect of triacylglycerol chain-length on food-intake in domestic-fowl. Physiology and Behavior 1992, 51:1147-1150.
27. Diraison F., Large V., Brunengraber H., Beylot M. Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycaemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty acid oxidation in NIDDM. Diabetologia 1998, 41:212-220.
28. Dobbins R.L., Szczepaniak L.S., Bentley B., Esser V., Myhill J., Mcgarry J.D. Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes 2001, 50:123-130.
29. Douglas B.R., Jansen J.B.M.J., Dejong A.J.L., Lamers C.B.H.W. Effect of various triglycerides on plasma cholecystokinin levels in rats. Journal of Nutrition 1990, 120:686-690.
30. Drewnowski A. Energy density, palatability, and satiety: implications for weight control. Nutrition Review 1998, 56:347-353.
31. Dulloo A.G., Fathi M., Mensi N., Girardier L. Twenty-four-hour energy expenditure and urinary catecholamines of humans consuming low-to-moderate amounts of medium-chain triglycerides: a dose-response study in a human respiratory chamber. European Journal of Clinical Nutrition 1996, 50:152-158.
32. Eaton S. Control of mitochondrial beta-oxidation flux. Progress in Lipid Research 2002, 41:197-239.
33. Field C.J., Schley P.D. Evidence for potential mechanisms for the effect of conjugated linoleic acid on tumor metabolism and immune function: lessons from n-3 fatty acids. American Journal of Clinical Nutrition 2004, 79:1190S-S1198S.
34. Foley J.E. Rationale and application of fatty-acid oxidation inhibitors in treatment of diabetes-mellitus. Diabetes Care 1992, 15:773-784.
35. Friedman M.I. Body-fat and the metabolic control of food-intake. International Journal of Obesity 1990, 14:53-67.
36. Friedman M.I. Fuel partitioning and food intake. American Journal of Clinical Nutrition 1998, 67:513S-S518S.
37. Friedman M.I., Harris R.B., Ji H., Ramirez I., Tordoff M.G. Fatty acid oxidation affects food intake by altering hepatic energy status. American Journal of Physiology - Regulatory Integrative and Comparative Physiology 1999, 276:R1046-R1053.
38. Furuse M., Choi Y.H., Mabayo R.T., Okumura J.I. Feeding-behavior in rats fed diets containing medium chain triglyceride. Physiology and Behavior 1992, 52:815-817.
39. Gaullier J.M., Halse J., Hoye K., et al. Conjugated linoleic acid supplementation for 1y reduces body fat mass in healthy overweight humans. American Journal of Clinical Nutrition 2004, 79:1118-1125.
40. Gavino V.C., Gavino G., Leblanc M.J., Tuchweber B. An isomeric mixture of conjugated linoleic acids but not pure cis-9, trans-11-octadecadienoic acid affects body weight gain and plasma lipids in hamsters. Journal of Nutrition 2000, 130:27-29.
41. Geary N. Is the control of fat ingestion sexually differentiated?. Physiology and Behavior 2004, 83:659-671.
42. Gupta G., Cases J.A., She L., et al. Ability of insulin to modulate hepatic glucose production in aging rats is impaired by fat accumulation. American Journal of Physiology - Endocrinology and Metabolism 2000, 278:E985-E991.
43. Hill J.O., Peters J.C., Lin D., Yakubu F., Greene H., Swift L. Lipid-accumulation and body-fat distribution is influenced by type of dietary-fat fed to rats. International Journal of Obesity 1993, 17:223-236.
44. Hopman W.P.M., Jansen J.B.M.J., Rosenbusch G., Lamers C.B.H.W. Effect of equimolar amounts of long-chain triglycerides and medium-chain triglycerides on plasma cholecystokinin and gallbladder contraction. American Journal of Clinical Nutrition 1984, 39:356-359.
45. Horn C.C., Ji H., Friedman M.I. Etomoxir, a fatty acid oxidation inhibitor, increases food intake and reduces hepatic energy status in rats. Physiology and Behavior 2004, 81:157-162.
46. Houseknecht K.L., Vanden Heuvel J.P., Moya-Camarena S.Y., et al. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochemical and Biophysical Research Communications 1998, 244:678-682.
47. Huang X.F., Xin X., Mclennan P., Storlien L. Role of fat amount and type in ameliorating diet-induced obesity: insights at the level of hypothalamic arcuate nucleus leptin receptor, neuropeptide Y and pro-opiomelanocortin mRNA expression. Diabetes Obesity and Metabolism 2004, 6:35-44.
48. Huot I., Paradis G., Ledoux M. Factors associated with overweight and obesity in Quebec adults. International Journal of Obesity 2004, 28:766-774.
49. Jambor De Sousa U.L., Leonhardt M., Langhans W. Effect of hepatic portal vein (HPV) caprylic acid (CA) infusion on saccharin preference and gastric emptying in male rats. Appetite 2003, 40:A338-A339.
50. Ji H., Graczyk-Milbrandt G., Friedman M.I. Metabolic inhibitors synergistically decrease hepatic energy status and increase food intake. American Journal of Physiology - Regulatory Integrative and Comparative Physiology 2000, 278:R1579-R1582.
51. Kahler A., Zimmermann M., Langhans W. Suppression of hepatic fatty acid oxidation and food intake in men. Nutrition 1999, 15:819-828.
52. Kamphuis M.M.J.W., Lejeune M.P.G.M., Saris W.H.M., Westerterp-Plantenga M.S. The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. International Journal of Obesity 2003, 27:840-847.
53. Kasai M., Nosaka N., Maki H., et al. Comparison of diet-induced thermogenesis of foods containing medium-versus long-chain triacylglycerols. Journal of Nutritional Science and Vitaminology 2002, 48:536-540.
54. Kim E.K., Miller I., Landree L.E., et al. Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment. American Journal of Physiology - Endocrinology and Metabolism 2002, 283:E867-E879.
55. Kim E.K., Miller I., Aja S., et al. C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase. Journal of Biological Chemistry 2004, 279:19970-19976.
56. Kopelman P.G. Obesity as a medical problem. Nature 2000, 404:635-643.
57. Kraegen E.W., Cooney G.J., Ye J.M., Thompson A.L., Furler S.M. The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type 2 diabetes and obesity. Experimental and Clinical Endocrinology and Diabetes 2001, 109:S189-201.
58. Krotkiewski M. Value of VLCD supplementation with medium chain triglycerides. International Journal of Obesity 2001, 25:1393-1400.
59. Kumar M.V., Shimokawa T., Nagy T.R., Lane M.D. Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:1921-1925.
60. Landree L.E., Hanlon A.L., Strong D.W., et al. C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism. Journal of Biological Chemistry 2004, 279:3817-3827.
61. Langhans W. Role of the liver in the metabolic control of eating: what we know - and what we do not know. Neuroscience and Biobehavioral Reviews 1996, 20:145-153.
62. Langhans W. Role of the liver in the control of glucose-lipid utilization and body weight. Current Opinion in Clinical Nutrition and Metabolic Care 2003, 6:449-455.
63. Langhans W., Scharrer E. Evidence for a vagally mediated satiety signal derived from hepatic fatty-acid oxidation. Journal of the Autonomic Nervous System 1987, 18:13-18.
64. Langhans W., Scharrer E. Role of fatty-acid oxidation in control of meal pattern. Behavioral and Neural Biology 1987, 47:7-16.
65. Larsson S.C., Kumlin M., Ingelman-Sundberg M., Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. American Journal of Clinical Nutrition 2004, 79:935-945.
66. Loftus T.M., Jaworsky D.E., Frehywot G.L., et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 2000, 288:2379-2381.
67. Lutz T.A., Diener M., Scharrer E. Intraportal mercaptoacetate infusion increases afferent activity in the common hepatic vagus branch of the rat. American Journal of Physiology - Regulatory Integrative and Comparative Physiology 1997, 273:R442-R445.
68. Madsen L., Rustan A.C., Vaagenes H., Berge K., Dyroy E., Berge R.K. Eicosapentaenoic and docosahexaenoic acid affect mitochondrial and peroxisomal fatty acid oxidation in relation to substrate preference. Lipids 1999, 34:951-963.
69. Maggio C.A., Koopmans H.S. Food-intake after intra-gastric meals of short-chain, medium-chain, or long-chain triglyceride. Physiology and Behavior 1982, 28:921-926.
70. Martin J.C., Gregoire S., Siess M.H. Effects of conjugated linoleic acid isomers on lipid-metabolizing enzymes in male rats. Lipids 2000, 35:91-98.
71. Mcleod R.S., Leblanc A.M., Langille M.A., Mitchell P.L., Currie D.L. Conjugated linoleic acids, atherosclerosis, and hepatic very-low-density lipoprotein metabolism. American Journal of Clinical Nutrition 2004, 79:1169S-S1174S.
72. Meckling K.A., O'sullivan C., Saari D. Comparison of a low-fat diet to a low-carbohydrate diet on weight loss, body composition, and risk factors for diabetes and cardiovascular disease in free-living, overweight men and women. Journal of Clinical Endocrinology and Metabolism 2004, 89:2717-2723.
73. Minokoshi Y., Alquier T., Furukawa N., et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428:569-574.
74. Morgan K., Obici S., Rossetti L. Hypothalamic responses to long-chain fatty acids are nutritionally regulated. Journal of Biological Chemistry 2004, 279:31139-31148.
75. Mori T.A., Burke V., Puddey I.B., et al. Purified eicosapentaenoic and docosa-hexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. American Journal of Clinical Nutrition 2000, 71:1085-1094.
76. Mosca C.L., Marshall J.A., Grunwald G.K., Cornier M.A., Baxter J. Insulin resistance as a modifier of the relationship between dietary fat intake and weight gain. International Journal of Obesity 2004, 28:803-812.
77. Moya-Camarena S.Y., Belury M.A. Species differences in the metabolism and regulation of gene expression by conjugated linoleic acid. Nutrition Reviews 1999, 57:336-340.
78. Moya-Camarena S.Y., Vanden Heuvel J.P., Blanchard S.G., Leesnitzer L.A., Belury M.A. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. Journal of Lipid Research 1999, 40:1426-1433.
79. Nakamura T., Yoshihara D., Ohmori T., Yanai M., Takeshita Y. Effects of diet high in medium-chain triglyceride on plasma ketone, glucose, and insulin concentrations in enterectomized and normal rats. Journal of Nutritional Science and Vitaminology 1994, 40:147-159.
80. Noguchi O., Takeuchi H., Kubota F., Tsuji H., Aoyama T. Larger diet-induced thermogenesis and less body fat accumulation in rats fed medium-chain triacylglycerols than in those fed long-chain triacylglycerols. Journal of Nutritional Science and Vitaminology 2002, 48:524-529.
81. Obici S., Feng Z.H., Arduini A., Conti R., Rossetti L. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nature Medicine 2003, 9:756-761.
82. Obici S., Feng Z.H., Morgan Y., Stein D., Karkanias G., Rossetti L. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 2002, 51:271-275.
83. Obici S., Rossetti L. Minireview: nutrient sensing and the regulation of insulin action and energy balance. Endocrinology 2003, 144:5172-5178.
84. Office Of The Surgeon General The surgeon general's call to action to prevent and decrease overweight and obesity 2001, http://www.surgeongeneral.gov/library.
85. Ostrowska E., Muralitharan M., Cross R.F., Bauman D.E., Dunshea F.R. Dietary conjugated linoleic acids increase lean tissue and decrease fat deposition in growing pigs. Journal of Nutrition 1999, 129:2037-2042.
86. Oudart H., Groscolas R., Calgari C., et al. Brown fat thermogenesis in rats fed high-fat diets enriched with n-3 polyunsaturated fatty acids. International Journal of Obesity 1997, 21:955-962.
87. Pariza M.W. Perspective on the safety and effectiveness of conjugated linoleic acid. American Journal of Clinical Nutrition 2004, 79:1132S-S1136S.
88. Pariza M.W., Ashoor S.H., Chu F.S., Lund D.B. Effects of temperature and time on mutagen formation in pan-fried hamburger. Cancer Letters 1979, 7:63-69.
89. Pariza M.W., Park Y., Cook M.E. Conjugated linoleic acid and the control of cancer and obesity. Toxicological Sciences 1999, 52:107-110.
90. Park E.A., Steffen M.L., Song S.L., Park V.M., Cook G.A. Cloning and characterization of the promoter for the liver isoform of the rat carnitine palmitoyltransferase I (L-CPT I) gene. Biochemical Journal 1998, 330:217-224.
91. Park Y., Storkson J.M., Albright K.J., Liu W., Pariza M.W. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 1999, 34:235-241.
92. Rahman S.M., Wang Y., Yotsumoto H., et al. Effects of conjugated linoleic acid on serum leptin concentration, body-fat accumulation, and beta-oxidation of fatty acid in OLETF rats. Nutrition 2001, 17:385-390.
93. Randle P.J. Regulatory interactions between lipids and carbohydrates: The glucose fatty acid cycle after 35 years. Diabetes - Metabolism Reviews 1998, 14:263-283.
94. Randle P.J., Garland P.B., Newsholme E.A., Hales C.N. Glucose fatty-acid cycle - its role in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet 1963, 1:785-789.
95. Ratheiser K., Schneeweiss B., Waldhausl W., et al. Inhibition by etomoxir of carnitine palmitoyltransferase-I reduces hepatic glucose-production and plasma-lipids in noninsulin-dependent diabetes-mellitus. Metabolism - Clinical and Experimental 1991, 40:1185-1190.
96. Riserus U., Basu S., Jovinge S., Fredrikson G.N., Arnlov J., Vessby B. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein - a potential link to fatty acid-induced insulin resistance. Circulation 2002, 106:1925-1929.
97. Riserus U., Smedman A., Basu S., Vessby B. Metabolic effects of conjugated linoleic acid in humans: the Swedish experience. American Journal of Clinical Nutrition 2004, 79:1146S-S1148S.
98. Riserus U., Vessby B., Arner P., Zethelius B. Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia 2004, 47:1016-1019.
99. Ritter R.C. Gastrointestinal mechanisms of satiation for food. Physiology and Behavior 2004, 81:249-273.
100. Ritter S., Taylor J.S. Capsaicin abolishes lipoprivic but not glucoprivic feeding in rats. American Journal of Physiology - Regulatory Integrative and Comparative Physiology 1989, 256:R1232-R1239.
101. Ritter S., Taylor J.S. Vagal sensory neurons are required for lipoprivic but not glucoprivic feeding in rats. American Journal of Physiology - Regulatory Integrative and Comparative Physiology 1990, 258:R1395-R1401.
102. Rivellese A.A., De Natale C., Lilli S. Type of dietary fat and insulin resistance. Lipids and Insulin Resistance: the Role of Fatty Acid Metabolism and Fuel Partitioning 2002, 967:329-335.
103. Roche H.M., Noone E., Sewter C., et al. Isomer-dependent metabolic effects of conjugated linoleic acid - insights from molecular markers sterol regulatory element-binding protein-1c and LXR alpha. Diabetes 2002, 51:2037-2044.
104. Rolls B.J. The role of energy density in the overconsumption of fat. Journal of Nutrition 2000, 130:268S-S271S.
105. Rubi B., Antinozzi P.A., Herrero L., et al. Adenovirus-mediated overexpression of liver carnitine palmitoyltransferase I in INS1E cells: effects on cell metabolism and insulin secretion. Biochemical Journal 2002, 364:219-226.
106. Ryder J.W., Portocarrero C.P., Song X.M., et al. Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes 2001, 50:1149-1157.
107. Sakono M., Miyanaga F., Kawahara S., et al. Dietary conjugated linoleic acid reciprocally modifies ketogenesis and lipid secretion by the rat liver. Lipids 1999, 34:997-1000.
108. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
109. Samaha F.F., Iqbal N., Seshadri P., et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. New England Journal of Medicine 2003, 348:2074-2081.
110. Saris W.H.M., Astrup A., Prentice A.M., et al. Randomized controlled trial of changes in dietary carbohydrate/fat ratio and simple vs complex carbohydrates on body weight and blood lipids: the CARMEN study. International Journal of Obesity 2000, 24:1310-1318.
111. Satia-Abouta J., Patterson R.E., Schiller R.N., Kristal A.R. Energy from fat is associated with obesity in US men: Results from the prostate cancer prevention trial. Preventive Medicine 2002, 34:493-501.
112. Scharrer E. Control of food intake by fatty acid oxidation and ketogenesis. Nutrition 1999, 15:704-714.
113. Scharrer E., Langhans W. Control of food-intake by fatty-acid oxidation. American Journal of Physiology - Regulatory Integrative and Comparative Physiology 1986, 250:R1003-R1006.
114. Seifter S., Englard S. The Liver: Biology and Pathobiology. Energy metabolism. 1994, 323-364. Raven Press, Ltd, New York. 3rd edn. I.M. Arias, J.L. Boyer, N. Fausto, W.B. Jakoby, D.A. Schachter, D.A. Shafritz (Eds.).
115. Sekiya M., Yahagi N., Matsuzaka T., et al. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 2003, 38:1529-1539.
116. Sergeyev V., Broberger C., Gorbatyuk O., Hokfelt T. Effect of 2-mercaptoacetate and 2-deoxy-D-glucose administration on the expression of NPY, AGRP, POMC, MCH and hypocretin/orexin in the rat hypothalamus. Neuroreport 2000, 11:117-121.
117. Sharman M.J., Gomez A.L., Kraemer W.J., Volek J.S. Very low-carbohydrate and low-fat diets affect fasting lipids and postprandial lipernia differently in overweight men. Journal of Nutrition 2004, 134:880-885.
118. Singer L.K., York D.A., Bray G.A. Macronutrient selection following 2-deoxy-D-glucose and mercaptoacetate administration in rats. Physiology and Behavior 1998, 65:115-121.
119. Singerkoegler L.K., Magluyan P., Ritter S. The effects of low-, medium-, and high-fat diets on 2-deoxy-D-glucose- and mercaptoacetate-induced feeding. Physiology and Behavior 1996, 60:321-323.
120. Sisk M.B., Hausman D.B., Martin R.J., Azain M.J. Dietary conjugated linoleic acid reduces adiposity in lean but not obese Zucker rats. Journal of Nutrition 2001, 131:1668-1674.
121. Soria A., Chicco A., D'alessandro M.E., Rossi A., Lombardo Y.B. Dietary fish oil reverse epididymal tissue adiposity, cell hypertrophy and insulin resistance in dyslipemic sucrose fed rat model. Journal of Nutritional Biochemistry 2002, 13:209-218.
122. St Onge M.P., Jones P.J. Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity. Journal of Nutrition 2002, 132:329-332.
123. Steffen M.L., Harrison W.R., Elder F.F.B., Cook G.A., Park E.A. Expression of the rat liver carnitine palmitoyltransferase I (CPT-I alpha) gene is regulated by Sp1 and nuclear factor Y: chromosomal localization and promoter characterization. Biochemical Journal 1999, 340:425-432.
124. Storlien L.H., Kraegen E.W., Chisholm D.J., Ford G.L., Bruce D.G., Pascoe W.S. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987, 237:885-888.
125. Stubbs R.J., Harbron C.G. Covert manipulation of the ratio of medium-to long-chain triglycerides in isoenergetically dense diets: effect on food intake in ad libitum feeding men. International Journal of Obesity 1996, 20:435-444.
126. Takahashi K.A., Smart J.L., Liu H.Y., Cone R.D. The anorexigenic fatty acid synthase inhibitor, C75, is a nonspecific neuronal activator. Endocrinology 2004, 145:184-193.
127. Takahashi Y., Ide T. Dietary n-3 fatty acids affect mRNA level of brown adipose tissue uncoupling protein 1, and white adipose tissue leptin and glucose transporter 4 in the rat. British Journal of Nutrition 2000, 84:175-184.
128. Taylor C.G., Zahradka P. Dietary conjugated linoleic acid and insulin sensitivity and resistance in rodent models. American Journal of Clinical Nutrition 2004, 79:1164S-S1168S.
129. Thupari J.N., Kim E.K., Moran T.H., Ronnett G.V., Kuhajda F.P. Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass. American Journal of Physiology - Endocrinology and Metabolism 2004, 287:E97-104.
130. Thupari J.N., Landree L.E., Ronnett G.V., Kuhajda F.P. C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:9498-9502.
131. Tso P., Liu M. Ingested fat and satiety. Physiology and Behavior 2004, 81:275-287.
132. Tso P., Sun W., Liu M. Gastrointestinal satiety signals - IV. Apolipoprotein A-IV. American Journal of Physiology - Gastrointestinal and Liver Physiology 2004, 286:G885-G890.
133. Tsuboyama-Kasaoka N., Takahashi M., Tanemura K., et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 2000, 49:1534-1542.
134. Tsuji H., Kasai M., Takeuchi H., Nakamura M., Okazaki M., Kondo K. Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. Journal of Nutrition 2001, 131:2853-2859.
135. Van Wymelbeke V., Himaya A., Louis-Sylvestre J., Fantino M. Influence of medium-chain and long-chain triacylglycerols on the control of food intake in men. American Journal of Clinical Nutrition 1998, 68:226-234.
136. Van Wymelbeke V., Louis-Sylvestre J., Fantino M. Substrate oxidation and control of food intake in men after a fat-substitute meal compared with meals supplemented with an isoenergetic load of carbohydrate, long-chain triacylglyc-erols, or medium-chain triacylglycerols. American Journal of Clinical Nutrition 2001, 74:620-630.
137. Wang J., Akabayashi A., Yu H.J., et al. Hypothalamic galanin: control by signals of fat metabolism. Brain Research 1998, 804:7-20.
138. Wang Y.W., Jones P.J.H. Dietary conjugated linoleic acid and body composition. American Journal of Clinical Nutrition 2004, 79:1153S-S1158S.
139. West D.B., Delany J.P., Camet P.M., Blohm F., Truett A.A., Scimeca J. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. American Journal of Physiology - Regulatory Integrative and Comparative Physiology 1998, 275:R667-R672.
140. Westerterp-Plantenga M.S. Analysis of energy density of food in relation to energy intake regulation in human subjects. British Journal of Nutrition 2001, 85:351-361.
141. Westerterp-Plantenga M.S. The significance of protein in food intake and body weight regulation. Current Opinion in Clinical Nutrition and Metabolic Care 2003, 6:635-638.
142. Westman E.C., Yancy W.S., Edman J.S., Tomlin K.F., Perkins C.E. Effect of 6-month adherence to a very low carbohydrate diet programme. American Journal of Medicine 2002, 113:30-36.
143. Willett W.C. Is dietary fat a major determinant of body fat?. American Journal of Clinical Nutrition 1998, 67:556S-S562S.
144. Williams J.R., Browning E.T., Scholz R., Kreisber R.A., Fritz I.B. Inhibition of fatty acid stimulation of gluconeogenesis by (+)-decanoylcarnitine in perfused rat liver. Diabetes 1968, 17:194-208.
145. Wood P.A., Kurtz D.M., Cox K.B., et al. Progress in Obesity Research. Role of genetic deficiency of fatty acid oxidation in metabolic syndrome/obesity. 2003, 293-296. John Libbey Eurotext Ltd, Esher, UK. 9th edn. G. Medeiros-Neto, A. Halpern, C. Bouchard (Eds.).
146. Wood P.A. Genetically modified mouse models for disorders of fatty acid metabolism: Pursuing the nutrigenomics of insulin resistance and type 2 diabetes. Nutrition 2004, 20:121-126.
147. Woodman R.J., Mori T.A., Burke V., Puddey I.B., Watts G.F., Beilin L.J. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. American Journal of Clinical Nutrition 2002, 76:1007-1015.
148. World Health Organization (WHO) Obesity and overweight (WHO global strategy on diet, physical activity and health) 2004, http://www.who.int/topics/obesity/en/.
149. Yamasaki M., Mansho K., Mishima H., et al. Effect of dietary conjugated linoleic acid on lipid peroxidation and histological change in rat liver tissues. Journal of Agricultural and Food Chemistry 2000, 48:6367-6371.
150. Yancy W.S., Olsen M.K., Guyton J.R., Bakst R.P., Westman E.C. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia - a randomized, controlled trial. Annals of Internal Medicine 2004, 140:769-777.
151. Zhu Z., Zheng T., Lee C.G., Homer R.J., Elias J.A. Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling. Seminars in Cell and Developmental Biology 2002, 13:121-128.